A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months
Article in Open Forum Infectious Diseases (August 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Open Forum Infectious Diseases (August 2024)
Article in Frontiers in Pediatrics (August 2024)
Preprint in bioRxiv (July 2024)